Milestones in atypical and secondary Parkinsonisms.Mov Disord. 2011 May; 26(6):1083-95.MD
Abstract
During the last decades, atypical parkinsonian disorders such as multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration along with secondary parkinsonian disorders have been increasingly recognized as important causes of parkinsonism. Although treatment options are largely limited to date, remarkable progress has occurred through advances in the fields of molecular biology and diagnostic neuroimaging, resulting in intense preclinical drug discovery programs. Early-investigation-assisted clinical diagnosis has become more crucial than ever because disease-modifying therapies will hopefully become available within this decade.
Links
MeSH
Pub Type(s)
Historical Article
Journal Article
Review
Language
eng
PubMed ID
21626553
Citation
Wenning, Gregor K., et al. "Milestones in Atypical and Secondary Parkinsonisms." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 26, no. 6, 2011, pp. 1083-95.
Wenning GK, Litvan I, Tolosa E. Milestones in atypical and secondary Parkinsonisms. Mov Disord. 2011;26(6):1083-95.
Wenning, G. K., Litvan, I., & Tolosa, E. (2011). Milestones in atypical and secondary Parkinsonisms. Movement Disorders : Official Journal of the Movement Disorder Society, 26(6), 1083-95. https://doi.org/10.1002/mds.23713
Wenning GK, Litvan I, Tolosa E. Milestones in Atypical and Secondary Parkinsonisms. Mov Disord. 2011;26(6):1083-95. PubMed PMID: 21626553.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Milestones in atypical and secondary Parkinsonisms.
AU - Wenning,Gregor K,
AU - Litvan,Irene,
AU - Tolosa,Eduardo,
PY - 2011/6/1/entrez
PY - 2011/6/1/pubmed
PY - 2011/10/1/medline
SP - 1083
EP - 95
JF - Movement disorders : official journal of the Movement Disorder Society
JO - Mov Disord
VL - 26
IS - 6
N2 - During the last decades, atypical parkinsonian disorders such as multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration along with secondary parkinsonian disorders have been increasingly recognized as important causes of parkinsonism. Although treatment options are largely limited to date, remarkable progress has occurred through advances in the fields of molecular biology and diagnostic neuroimaging, resulting in intense preclinical drug discovery programs. Early-investigation-assisted clinical diagnosis has become more crucial than ever because disease-modifying therapies will hopefully become available within this decade.
SN - 1531-8257
UR - https://www.unboundmedicine.com/medline/citation/21626553/Milestones_in_atypical_and_secondary_Parkinsonisms_
L2 - https://doi.org/10.1002/mds.23713
DB - PRIME
DP - Unbound Medicine
ER -